Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Neurosurgery|November 16, 2019
Cushing's disease: a prospective case-control study of health-related quality of life and cognitive status before and after surgeryBarbara Zarino, Elisa Verrua, Emanuele Ferrante, et al.
The Journal of Clinical Investigation|May 3, 2022
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndromeSilvia Arcangeli, Camilla Bove, Claudia Mezzanotte, et al.
Operative Neurosurgery (Hagerstown, Md.)|June 19, 2026
Iterative Virtual and Physical Simulation for Staged Separation of Total Vertical Craniopagus: The Avatar Patient Approach to Conjoined TwinsCarlo G Giussani, Fabio Mazzoleni, Andrea Marchesi, et al.
Frontiers in Immunology|June 4, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemiaAlessandro Bruno, Francesca Lorentino, Matteo G Carrabba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2015
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem CellsNicoletta Cieri, Raffaella Greco, Lara Crucitti, et al.
International Journal of Cancer|January 26, 2017
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumorsE Peverelli, E Giardino, D Treppiedi, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Leukemia|November 6, 2014
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantationL Crucitti, R Crocchiolo, C Toffalori, et al.
Frontiers in Immunology|September 2, 2025
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndromeEdoardo Campodonico, Piera Angelillo, Matteo Doglio, et al.
Bone Marrow Transplantation|January 14, 2018
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patientsRaffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, et al.
Pageof 5